[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 756]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Advisory Commission on Childhood Vaccines (ACCV) has
scheduled public meetings for the 2019 calendar year (CY). Information
about ACCV, agendas, and materials for these meetings can be found on
the ACCV website at: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.
DATES: ACCV meetings will begin at 10:00 a.m. ET on March 7-8, 2019;
June 6-7, 2019; September 5-6, 2019; and December 5-6, 2019.
ADDRESSES: Meetings may be held in-person, by teleconference, and/or
Adobe Connect webinar. In-person ACCV meetings will be held at 5600
Fishers Lane, Rockville, Maryland 20857. Instructions for joining the
meetings either in person or remotely will be posted on the ACCV
website 30 business days before the date of the meeting. For meeting
information updates, go to the ACCV website meeting page: https://www.hrsa.gov/advisory-committees/vaccines/meetings.html.
FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst,
Division of Injury Compensation Programs (DICP), HRSA, 5600 Fishers
Lane, 08N146B, Rockville, Maryland 20857; 301-443-6593; or
[email protected].
SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of
the Public Health Service Act (42 U.S.C. 300aa-19), as enacted by
Public Law (Pub. L.) 99-660, and as subsequently amended, and advises
the Secretary of HHS (Secretary) on issues related to implementation of
the National Vaccine Injury Compensation Program (VICP). For CY 2019
meetings, agenda items may include, but are not limited to, updates
from DICP, the Department of Justice, the National Vaccine Program
Office, the Immunization Safety Office, National Institute of Allergy
and Infectious Diseases, and the Center for Biologics Evaluation and
Research. Since priorities dictate meeting times, be advised that
locations and agenda items are subject to change. Refer to the ACCV
website listed above for all current and updated information concerning
the CY 2019 ACCV meetings, including draft agendas and meeting
materials that will be posted before the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to the ACCV should be
sent to Annie Herzog using the contact information above at least five
business days before the meeting date(s).
Individuals who need special assistance or another reasonable
accommodation should notify Annie Herzog at the address and phone
number listed above at least 10 business days before the meeting(s)
they wish to attend. Since all in person meetings will occur in a
federal government building, attendees must go through a security check
to enter the building. Non-U.S. Citizen attendees must notify HRSA of
their planned attendance at least 10 business days prior to the meeting
in order to facilitate their entry into the building. All attendees are
required to present government-issued identification prior to entry.
Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2019-00439 Filed 1-30-19; 8:45 am]
BILLING CODE 4165-15-P